Mitsui Global Investment is a company that provides financial support and guidance to entrepreneurs with innovative business plans and aspirations.

Mitsui Global Investment

Here at Mitsui Global Investment, we get excited about cutting-edge technologies and scientific breakthroughs. Passionate entrepreneurs and forward-thinking investors inspire us, and we hope to do the same.  

We enjoy getting to know the teams we invest in and cherish opportunities to help out and provide value-add support.  With the diversity and knowledge amassed through our years as a global enterprise, we bring a fresh eye to new business.  

We have been investing for over 20 years in venture opportunities with over 100 portfolio companies and 35 exits, and are currently seeking new investment opportunities.  

Please visit our website us if you'd like to learn more.

Mitsui & Co. Global Investment, Inc.

Congratulations to the QurAlis team for closing a licensing deal with Eli Lilly for the development of their QRL-204 compound.  This compound will potentially restore UNC13a function in patients with ALS and FTD. Amazing work! https://lnkd.in/ePTXJvH9 Kasper Roet Dan Elbaum Angela Genge, MD, FRCP(C), eMBA Vikas Sharma Anne Whitaker Johannes Fruehauf Chris Thomajan Kristine Kelly, MBA Roel Bulthuis Ivan Burkov Jeffrey Moore Peter Wallach Jonathan Behr Kiyoshi Okubo Sunao Nishimura Aya Runderkamp Kazufumi Nakamura Kinji Fuchikami Yukitaka Kojima, CFA Irene Mingozzi Orie Schneider Sue Yasuko Nagakura Makiko Kikuchi Qing (Susie) Shen Yasuhiro S. Atsuko Chitose Michael S. Yu Reiko Namikawa, MD. Ph.D. Yoichiro Miwa Caroline Pinkney

Great update from our newest portfolio company, Reunion Neuroscience, who just published results from their preclinical studies.  Excellent work and one step further in developing a therapeutic to treat depressive disorders! Welcome to the Mitsui family! Kazufumi Nakamura Yukitaka Kojima, CFAQing (Susie) Shen  Kiyoshi Okubo Sunao Nishimura Makiko Kikuchi  Aya Runderkamp Orie Schneider Kinji Fuchikami Irene Mingozzi Caroline Pinkney 
https://lnkd.in/drsquEYU

We are happy to announce the closing of Leash Laboratories' seed financing round, one of our newest portfolio companies innovating the drug discovery space. Congratulations to the Leash team! Yukitaka Kojima, CFA

MITS

COM:MITSUI-GLOBAL

Mitsui Global Investment